US Stock Market Move | Lilly (LLY.US) rose by 3.8%, with major Wall Street firms maintaining their "buy" rating.
As of the press deadline, the stock rose by 3.8% to $649.66.
On Monday, the stock price of Eli Lilly (LLY.US) rose, as of the time of writing, the stock was up 3.8% at $649.66. On the news front, Deutsche Bank Aktiengesellschaft analyst James Shin maintained a "buy" rating on Eli Lilly, but lowered the target price to $900. Analysts from Furry Group, Morgan Stanley, J.P. Morgan, Citigroup, and Truist Financial also maintained a "buy" rating on the stock.
Related Articles
US Stock Market Move | The CEO stated that the Q1 sales performance is unacceptable, causing C3.ai (AI.US) to plummet over 23%.
US Stock Market Move | Apply for a British electricity supply license Tesla, Inc. (TSLA.US) rises nearly 4%
US Stock Market Move | SoundHound AI (SOUN.US) surged over 16% and reached a partnership agreement with Acrelec in the field of voice AI platforms.
US Stock Market Move | The CEO stated that the Q1 sales performance is unacceptable, causing C3.ai (AI.US) to plummet over 23%.
US Stock Market Move | Apply for a British electricity supply license Tesla, Inc. (TSLA.US) rises nearly 4%
US Stock Market Move | SoundHound AI (SOUN.US) surged over 16% and reached a partnership agreement with Acrelec in the field of voice AI platforms.
RECOMMEND
CATL’s Jianxiawo Lithium Mine Halts Production; Will Lithium Carbonate Prices Reverse?
11/08/2025
Year-to-Date Southbound Stock Connect Inflows Exceed HKD 900 Billion for the First Time
11/08/2025
Gold Futures Reach Record High as Institutions Shift Focus to Long-Term Opportunities in Gold Stocks
11/08/2025
